全球微泡/超音波造影剂市场规模、份额、成长分析、按疾病领域（心血管疾病、肾臟疾病）、按应用（分子影像、药物传递）- 2024-2031 年产业预测

2022年全球微泡/超音波造影剂市场规模为18.7亿美元，预计将从2023年的19.4亿美元增长到2031年的26.6亿美元，在预测期内（2024-2031年）复合年增长率为4.00亿美元，在预测期内（2024-2031年）复合年增长率为4.00亿美元，在预测期内（2024-2031年）复合年增长率为4.00亿美元% 。

医学影像中用于增强 X 射线下液体或结构可视性的物质（称为造影剂或造影剂）通常对 X 射线是透明的。在对比超音波成像中，微泡在放射学和心臟病学中充当血池剂，在基因治疗、药物传输、分子成像和干细胞传输中广泛应用。这些微泡还可以透过与疾病特异性分子标记结合来发挥作用，提供一种有针对性的诊断手段。微泡的功能类似于静脉注射时循环中的红血球，在超音波脉衝下产生强烈的迴声，由于其与周围软组织气体的迴声不同，透过放大超音波反射或反向散射来增强超音波心动图的对比度。

目录

执行摘要

• 市场概况
• 命运之轮

研究方法论

• 资讯采购
• 二手和主要资料来源
• 市场规模估计
• 市场假设与限制

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战

主要市场洞察

• 技术分析
• 定价分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• 启动分析
• 原料分析
• 创新矩阵
• 管道产品分析
• 总体经济指标
• 顶级投资分析
• 成功的关键因素
• 竞争程度

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战
• 监管环境
• 波特分析
• 对未来颠覆的特别见解

按疾病领域分類的全球微泡/超音波造影剂市场

• 市场概况
• 心血管疾病
• 肾臟疾病
• 其他的

全球微泡/超音波造影剂市场（按应用）

• 市场概况
• 分子影像
• 药物输送
• 基因治疗
• 和干细胞输送

全球微泡/超音波造影剂市场规模（按地区）

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • MEA 的其余部分

竞争格局

• 前 5 名玩家比较
• 2023 年关键参与者的市场定位
• 主要市场参与者所采取的策略
• 最佳制胜策略
• 近期市集活动
• 主要公司市占率 (%), 2023

主要公司简介

• General Electric Company
• Bracco Imaging SpA
• Lantheus Holdings, Inc.
• Daiichi Sankyo Company, Limited
• Bayer AG
• Fujifilm Holdings Corporation
• Sanofi SA
• Siemens Healthineers AG
• Guerbet Group
• nanoPET Pharma GmbH
• MBI Co., Ltd.
• Trivitron Healthcare
• Unilife Corporation
• PTW Freiburg GmbH
• Esaote SpA
• Mindray Medical International Limited
• Samsung Electronics Co., Ltd.
• Shimadzu Corporation
• Philips Healthcare
• Canon Medical Systems Corporation

Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.87 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.66 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

A substance used in medical imaging to enhance the visibility of fluids or structures under X-rays, known as contrast media or contrast agent, is typically transparent to X-rays. In contrast ultrasound imaging, microbubbles serve as a blood pool agent in radiology and cardiology, finding extensive application in gene therapy, drug delivery, molecular imaging, and stem cell delivery. These microbubbles can also operate by binding to disease-specific molecular markers, offering a means of targeted diagnosis. Functioning akin to red blood cells in circulation upon intravenous injection, microbubbles generate strong echoes under ultrasound pulses, providing enhanced contrast in echocardiograms by amplifying ultrasound reflection or backscattering due to their differing echogenicity from surrounding soft tissue gases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbubbles/Ultrasound Contrast Agents Market Segmental Analysis

Microbubbles/Ultrasound Contrast Agents market is segmented on the basis of disease area, By application, and By Region. Whereas, Disease area is sub segmented into cardiovascular diseases, renal diseases, and others. By Application is sub segmented into the molecular imaging, drug delivery, gene therapy, and stem cells delivery. By Region is segmented on the basis of North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Drivers of the Global Microbubbles/Ultrasound Contrast Agents Market

The utilization of microbubbles and ultrasound contrast agents in molecular imaging is increasingly fueled by the rising requirement for targeted therapies and the necessity to monitor biomarker status in vascular endothelium. Over the projected period, the market for microbubbles/ultrasound contrast agents is expected to grow, propelled by advancements in ultrasound technologies, escalating demand for targeted diagnostic instruments, the inherent advantages of microbubbles/ultrasound contrast agents compared to conventional diagnostic methods, and a surge in chronic disease prevalence.

Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market

The global Microbubbles/Ultrasound Contrast Agents market faces a significant restraint due to the brief lifespan of microbubbles, hindering its growth prospects throughout the forecast period. Additionally, regulatory hurdles, limited reimbursement policies, and high manufacturing costs further impede market expansion, posing challenges to widespread adoption and innovation in ultrasound contrast agents.

Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market

In the fields of cardiology and radiology, microbubbles are employed as blood-pool agents in contrast ultrasound imaging but are increasingly acknowledged for their promise as targeted agents in molecular imaging. By incorporating ligand molecules that attach to disease-specific molecular markers, microbubbles can be tailored for functionality. This enables the monitoring of biomarker status in vascular endothelium, visualization of tumor vasculature, and imaging of inflammation, ischemia-reperfusion injury zones, and thrombi, presenting diverse clinical applications for molecular imaging utilizing microbubble-based ultrasound contrast agents.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Microbubbles/Ultrasound Contrast Agents Market by Disease Area

• Market Overview
• cardiovascular diseases
• renal diseases
• and others

Global Microbubbles/Ultrasound Contrast Agents Market by Application

• Market Overview
• molecular imaging
• drug delivery
• gene therapy
• and stem cells delivery

Global Microbubbles/Ultrasound Contrast Agents Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• General Electric Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• nanoPET Pharma GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MBI Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unilife Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTW Freiburg GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote SpA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments